Vaccine makers say IP waiver could hand technology to China and Russia
Proposal to suspend patent rights comes as poorer countries struggle to obtain Covid doses
Hasnain says:
...
“As industry lobbying has escalated in Washington, companies have warned in private meetings with US trade and White House officials that giving up the intellectual property rights could allow China and Russia to exploit platforms such as mRNA, which could be used for other vaccines or even therapeutics for conditions such as cancer and heart problems in the future.”
Posted on 2021-04-25T23:11:20+0000